Posted by Michael Wonder on 06 May 2021
Medicines Australia updated position on intellectual property (in light of TRIPS waiver)
6 May 2021 - Medicines Australia continues to express our sympathies to all those affected by the pandemic. The importance of accessible, lifesaving vaccines and treatments could not be more important.
The US Government’s decision to support a patent waiver on COVID-19 vaccines will not increase vaccine production nor increase the rate of vaccination in poorer countries.
